Antiviral efficacies of famciclovir, valaciclovir, and brivudin in disseminated herpes simplex virus type 1 infection in mice

Intervirology

Volumn 40, Issue 1, 1997, Pages 15-21

  Wutzler, Peter ^a   Ulbricht, Anton ^a   Färber, Inge ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Animal model; Brivudin; Famciclovir; HSV 1; Valaciclovir

Indexed keywords

5 (2 BROMOVINYL) 2' DEOXYURIDINE; ACICLOVIR; ANTIVIRUS AGENT; FAMCICLOVIR; VALACICLOVIR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; ENCEPHALITIS; HEPATITIS; HERPES; HERPES SIMPLEX VIRUS 1; LIVER; MORTALITY; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; VIRUS REPLICATION;

ANIMALIA; FELINE CALICIVIRUS; HERPES; HUMAN HERPESVIRUS 1;

EID: 0030793028     PISSN: 03005526     EISSN: 14230100     Source Type: Journal    
DOI: 10.1159/000150516     Document Type: Article

References (25)

1. Weller S, Blum MR, Doucette M, Burnette T, Cedcrbcrg DM, de Miranda P, Smiley LM: Pharmacokinetics of the acyclovir pro-drug valaciclovir after escalating single- and mulli-ple-dosc administration to normal volunteers, Clin Pharmacol Ther 1993:54:595-605.
2. Boyd MR, Boon JR, Fowles SE, Pagano K, Sutton D, Vere Hodge RA, Zussman BD: Some biological properties of BRL 42810, a well absorbed oral prodrug of the anti-herpesvirus agent BRL 39123 (abstract), Antiviral Res 1988;9:146.
3. Puc MA, Benct LZ: Pharmacokinetics of famciclovir in man, Antiviral Chem Chemother 1993;4(suppl l):47-55.
4. Vere Hodge RA, Cheng Y-C: The mode of action of pcnciclovir, Antiviral Chem Chemother 1993;4(suppl 1): 13-24.
5. Jacobson MA: Valaciclovir (BW256U87): The L-valyl ester of acyclovir, J Med Virol, 1993 (suppl 1); 150-153.
6. Shigeta S, Yokota T, Iwabuchi T, Baba M, Konno K, Ogata M, De Clercq E: Comparative efficacy of antiherpes drugs against various strains of varicella-zoster virus, J Infect Dis 1983:147:576-584.
7. Ulbricht A, Färber I, Wutzlcr P: Herpes simplex virus hepatitis in mice: Effects of treatment with trisodium phosphonoformat, Acta Virol (Praha) 1985:29:493-498.
8. Puchammer-Stöckel E, Popov-Kraupp T, Heinz FX, Mandl CW, Kunz C: Establishment of PCR for the early diagnosis of herpes simplex encephalitis, J Med Virol 1990;32:77-82.
9. Baxter RP, Phillips LE, Faro S, Hoffman L: Hepatitis due to herpes simplex virus in a nonpregnant patient: Treatment with acyclovir, SexTransm Dis 1986:13:174-176.
10. Goodman ZD, Ishak KG, Seslerhenn IA: Herpes simplex hepatitis in apparently immunocompetent adults, J Clin Pathol 1986:85: 694-699.
11. Mogensen SC, Teisner B, Andersen HK: Focal necrotic hepatitis in mice as a biological marker for differentiation of herpesvirus hominis tvpe I and tvpe 2, J Gen Virol 1974:25:151- 155.
12. Field HJ, Tcwari D, Sutton D, Thackray AM: Comparison of efficacies of famciclovir and valaciclovir against herpes simplex virus type 1 in a murine immunosuppression model, An-timicrob Agents Chemother 1995:39:1114- 1119.
13. Reefschlâger J, Wutzler P, Thiel K-D, Herrmann G: Treatment of experimental herpes simplex virus type I encephalitis in mice with (E)-5-(2-bromovinvl)- and 5-vinyl-l-p-D-arabi-nofuranosyluracil: Comparison with bromovi-nyl-deoxyuridinc and acyclovir, Antiviral Res 1986;6:83-93.
14. Park N-H, Pavan-Langston D, Mclean SL, Albert DM: Therapy of experimental herpes simplex virus encephalitis with aciclovir in mice, Antimicrob Agents Chemothcr 1979; 15:775- 779.
15. Reefschlagcr J, Wutzler P, Thiel K-D, Barwolf D, Langen P, Sprbssig M, Rosenthal HA: Effi-cacy of (E)-5-(2-bromovinyl)-2'-deoxyuridine against herpes simplex virus strains in cell culture and against experimental encephalitis in mice, Antiviral Res 1982;2:255-265.
16. Sutton D, Kern ER: Activity of famciclovir and penciclovir in HSV-infected animals: a review, Antiviral Chcm Chemothcr 1993:4(suppl 1): 37-46.
17. Boyd MR, Bacon TH, Sutton D: Antiherpesvirus activity of 9-4-hydroxy-3-hydroxymethyl-bul-l-yDguanine (BRL 39123) in animals. Antimicrob Agents Chemothcr 1988;32:358-363.
18. Goldthorpc SE, Boyd MR, Field HJ: Effects of penciclovir and famciclovir in a murine model of encephalitis induced by intranasal inoculation of herpes simplex virus type I, Antiviral Chem Chemothcr 1992;3:37-47.
19. Field HJ, Thackray AM: The effects of de-layed-onset chemotherapy using famciclovir or valaciclovir in a murine immunosuppression model for HSV-1, Antiviral Chem Chemothcr 1995;6:210-216.
20. Sutton D, Boyd MR: Comparative activity of penciclovir and acyclovir in mice infected in-traperitoneally with herpes simplex virus type 1 SC 16, Antimicrob Agents Chemothcr 1993: 37:642-645.
21. Ertl P, Snowden W, Lowe D, Miller W, Collins P, Littler E: A comparative study of the in vitro and in vivo antiviral activities of acyclovir and penciclovir, Antiviral Chem Chemothcr 1995: 6:89-97.
22. Field HJ, Anderson JR, Efstathiou S: A quantitative study of the effects of several nucleoside analogues on established herpes encephalitis in mice, J Gen Virol 1984:65:707-719.
23. De Clercq E, Zhang Z-X, Sim IS: Treatment of experimental herpes simplex virus encephalitis with (EF5-(2-bromovinyl-2'-dcoxyuridine in mice, Antimicrob Agents Chcmother 1982:22: 421-425.
24. Park N-H, Pavan-Langston D, DeClercq E: Efficacy of (E)-5-(2-bromovinyl)-2'-deoxyuridine in the treatment of experimental herpes simplex virus encephalitis in mice, Antiviral Res 1983:3:7-15.
25. Machida H, Takezawa J: Effect of I -fJ-2-arabi-nofuranosyl-E-5-(2-bromovinyl)uracil (brova-vir) on experimental infections in mice with herpes simplex virus type I strains of different degrees of virulence, Antimicrob Agents Che-mother 1990;43:691-696.